IGM Biosciences Appoints George Gauthier as Chief Commercial Officer Mr. Gauthier Brings 20 Years of Global Commercial Experience in the Life Sciences Industry April 12, 2021 07:00 ET | Source: IGM Biosciences IGM Biosciences Mountain View, California, UNITED STATES MOUNTAIN VIEW, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced the appointment of George A. Gauthier to the newly created position of Chief Commercial Officer. Mr. Gauthier joins IGM with twenty years of experience in global commercial strategy, marketing, sales and product development. Most recently, Mr. Gauthier was Vice President of Global Product Strategy for Breast and Gynecological Cancers at Genentech, where he led a global team in the creation and execution of commercial and product development strategies.